{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:50:45Z","timestamp":1794585045717,"version":"4.9.1"},"reference-count":46,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T00:00:00Z","timestamp":1757808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The management of patients with multiple primary malignancies (MPMs) is performed by a multidisciplinary team whose purpose is to individualize the treatment plan and to determine the strategies that will improve the patient\u2019s care. The most commonly encountered malignancies are prostate cancer, colorectal cancer, lung, and bladder cancer. Prostate cancer may be synchronous or metachronous with other cancer sites. The risk factors for MPMs are viral infections, genetic factors, environmental factors, and oncological treatments (chemotherapy and radiotherapy). Materials and Methods: In this retrospective cohort study, we analyzed 26 patients with either synchronous or metachronous prostate cancer with another cancer site, registered at \u201cSf. Apostol Andrei\u201d County Emergency Hospital in Galati, Romania, over a 15-year time interval (2010\u20132025).This paper presents the clinical and therapeutic characteristics and the staging of synchronous\/metachronous cancer sites. The stage of the disease was analyzed along with the time interval between the first cancer site and the second or the third cancer site occurrence; the undergone treatment was a multimodal one. Results: This paper discusses the analyzed cases and presents the articles published in the specialty literature regarding the stage of synchronous or metachronous prostate cancer with one or more cancer sites. The most common sites are presented, along with the importance of follow-up and a complex therapeutic management depending on the stage of primary tumors. Conclusions: This series represents a cohort study regarding synchronous\/metachronous prostate cancer with other cancer sites (26 cases over a 15-year time period). This case series adds more experience to the already existing experience in the literature, providing guidelines to clinicians in order to make the right decisions regarding the treatment of this disease.<\/jats:p>","DOI":"10.3390\/medicina61091666","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:56:51Z","timestamp":1757923011000},"page":"1666","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Synchronous\/Metachronous Prostate Cancer with Other Cancer Sites\u2014The Experience of a Single Center in Romania"],"prefix":"10.3390","volume":"61","author":[{"given":"Gabriela","family":"Rahnea-Nita","sequence":"first","affiliation":[{"name":"Specific Disciplines Department, The Faculty of Nursing and Midwifery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"M Hospital, 010903 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Dumitru","sequence":"additional","affiliation":[{"name":"The Department of Radiotherapy, \u201cSfantul Apostol Andrei\u201d Hospital, 800578 Galati, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Nechifor","sequence":"additional","affiliation":[{"name":"The Clinical Department, The Faculty of Medicine and Pharmacy, \u201cDunarea de Jos\u201d University of Galati, 800008 Galati, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana-Andreea","family":"Rahnea-Nita","sequence":"additional","affiliation":[{"name":"M Hospital, 010903 Bucharest, Romania"},{"name":"The Clinical Department, The Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian-Cornel","family":"Maier","sequence":"additional","affiliation":[{"name":"The Clinical Department, The Faculty of Medicine and Pharmacy, \u201cDunarea de Jos\u201d University of Galati, 800008 Galati, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana Florina","family":"Andronache","sequence":"additional","affiliation":[{"name":"The Preclinical Department, The Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Cernea","sequence":"additional","affiliation":[{"name":"The Department of Radiotherapy, \u201cSfantul Apostol Andrei\u201d Hospital, 800578 Galati, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Rebegea","sequence":"additional","affiliation":[{"name":"The Clinical Department, The Faculty of Medicine and Pharmacy, \u201cDunarea de Jos\u201d University of Galati, 800008 Galati, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura-Florentina","family":"Rebegea","sequence":"additional","affiliation":[{"name":"The Department of Radiotherapy, \u201cSfantul Apostol Andrei\u201d Hospital, 800578 Galati, Romania"},{"name":"The Clinical Department, The Faculty of Medicine and Pharmacy, \u201cDunarea de Jos\u201d University of Galati, 800008 Galati, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,14]]},"reference":[{"key":"ref_1","first-page":"1358","article-title":"Multiple Primary Malignant Tumors: A Survey of the Literature and Statistical Study","volume":"16","author":"Warren","year":"1932","journal-title":"Am. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Pan, S.Y., Huang, C.P., and Chen, W.C. (2022). Synchronous\/Metachronous Multiple Primary Malignancies: Review of Associated Risk Factors. Diagnostics, 12.","DOI":"10.3390\/diagnostics12081940"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/CMAR.S57378","article-title":"Multiple neoplasms, single primaries, and patient survival","volume":"6","author":"Amer","year":"2014","journal-title":"Cancer Manag. Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Coyte, A., Morrison, D.S., and McLoone, P. (2014). Second primary cancer risk\u2014The impact of applying different definitions of multiple primaries: Results from a retrospective population-based cancer registry study. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-272"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tanjak, P., Suktitipat, B., Vorasan, N., Juengwiwattanakitti, P., Thiengtrong, B., Songjang, C., Therasakvichya, S., Laiteerapong, S., and Chinswangwatanakul, V. (2021). Risks and cancer associations of metachronous and synchronous multiple primary cancers: A 25-year retrospective study. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08766-9"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1601-0825.2012.01950.x","article-title":"Association of HPV infections with second primary tumors in early-staged oral cavity cancer","volume":"18","author":"Huang","year":"2012","journal-title":"Oral Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Rotondo, J.C., Mazzoni, E., Bononi, I., Tognon, M., and Martini, F. (2019). Association Between Simian Virus 40 and Human Tumors. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00670"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.euf.2018.09.010","article-title":"The Role of Human Papilloma Virus in Penile Cancer Prevention and New Therapeutic Agents","volume":"5","author":"Schlenker","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10689-018-00117-1","article-title":"Recent advances in Lynch syndrome","volume":"18","author":"Biller","year":"2019","journal-title":"Fam. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1200\/EDBK_238977","article-title":"The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families","volume":"39","author":"Pilarski","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN Guidelines Insights: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years","volume":"209","author":"Concolino","year":"2016","journal-title":"Cancer Genet."},{"key":"ref_13","first-page":"1","article-title":"Environmental Factors Inducing Human Cancers","volume":"41","author":"Parsa","year":"2012","journal-title":"Iran. J. Public Health"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chen, P.-H., Mahmood, Q., Mariottini, G.L., Chiang, T.-A., and Lee, K.-W. (2017). Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers. BioMed Res. Int., 2017.","DOI":"10.1155\/2017\/3904098"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00066-018-1400-5","article-title":"Incidence of second primary cancers after radiotherapy combined with platinum and\/or cetuximab in head and neck cancer patients","volume":"195","author":"Elicin","year":"2019","journal-title":"Strahlenther. Und Onkol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e079559","DOI":"10.1136\/bmjopen-2023-079559","article-title":"Barriers and Challenges of Multidisciplinary Teams in Oncology Management: A Scoping Review Protocol","volume":"14","author":"Law","year":"2024","journal-title":"BMJ Open"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"86.e9","DOI":"10.1016\/j.jamda.2014.10.015","article-title":"Assessment of care problems in Romania: Feasibility and exploration","volume":"16","author":"Ghinescu","year":"2015","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_18","first-page":"339","article-title":"Multidisciplinary Team Meetings: Barriers to Implementation in Cancer Care","volume":"38","author":"He","year":"2024","journal-title":"Oncology"},{"key":"ref_19","first-page":"100580","article-title":"Does Multidisciplinary Team Management Improve Clinical Outcomes in NSCLC? A Systematic Review with Meta-Analysis","volume":"4","author":"Souza","year":"2023","journal-title":"JTO Clin. Res. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2147\/JMDH.S402348","article-title":"Characterizing Different Multidisciplinary Team Models Implemented Within One Comprehensive Cancer Center","volume":"16","author":"Alfieri","year":"2023","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Rahnea-Nita, R.A., Stoian, A.R., Anghel, R.M., Rebegea, L.F., Ciuhu, A.N., Bacinschi, X.E., Zgura, A.F., Trifanescu, O.G., Toma, R.V., and Constantin, G.B. (2023). The Efficacy of Immunotherapy in Long-Term Survival in Non-Small Cell Lung Cancer (NSCLC) Associated with the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH). Life, 13.","DOI":"10.3390\/life13061279"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chen, J., Zhang, D., Yan, W., Yang, D., and Shen, B. (2013). Translational Bioinformatics for Diagnostic and Prognostic Prediction of Prostate Cancer in the Next-Generation Sequencing Era. BioMed Res. Int., 2013.","DOI":"10.1155\/2013\/901578"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., and Mashele, S. (2022). Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules, 27.","DOI":"10.3390\/molecules27175730"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rahnea-Nita, R.-A., Rebegea, L.-F., Nechifor, A., Mare\u0219, C., Toma, R.-V., Stoian, A.-R., Ciuhu, A.-N., Andronache, L.-F., Constantin, G.B., and Rahnea-Nita, G. (2023). The Complexity of Treatments and the Multidisciplinary Team\u2014A Rare Case of Long-Term Progression\u2014Free Survival in Prostate Cancer until Development of Liver and Brain Metastases. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175579"},{"key":"ref_25","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"ref_26","first-page":"1265","article-title":"Paraneoplastic pemphigus associated with a hypopharynx squamous cell carcinoma. Case report authors","volume":"34","author":"Rebegea","year":"2018","journal-title":"Acta Medica Mediterr."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Chen, J., Xu, L., Hu, X., Zeng, H., and Liu, Z. (2024). Case report: Synchronous prostate cancer and renal cell carcinoma with prostate cancer-origin metastases to adrenal and renal hilar lymph nodes. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1412067"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13139-023-00798-2","article-title":"Synchronous Pulmonary Malignancy Detected During PSMA Ligand PET\/CT for Initial Staging of Prostate Cancer: A Case Report","volume":"57","author":"Bunnag","year":"2023","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.4103\/jcrt.JCRT_822_17","article-title":"A rare synchronous presentation of double primary malignancies\u2014Lung and prostate","volume":"17","author":"Sarkar","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.radcr.2020.08.069","article-title":"Prostate cancer and sarcoma: Challenges of synchronous malignancies","volume":"15","author":"Wali","year":"2020","journal-title":"Radiol. Case Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2340\/1651-226X.2025.42592","article-title":"Rising incidence trends of synchronous prostate and rectal cancers: A population-based study","volume":"64","author":"Edfelt","year":"2025","journal-title":"Acta Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Sidiqi, B., Nosrati, J., Wu, V., Kobritz, M., La Gamma, N., Whelan, R., Parashar, B., King, D., Tchelebi, L., and Herman, J. (2023). The Prevalence and Management of Synchronous Prostate and Rectal Cancer. Int. J. Radiat. Oncol. Biol. Phys., 117.","DOI":"10.1016\/j.ijrobp.2023.06.2398"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.31254\/jmr.2023.9503","article-title":"A Prostate Cancer Metachronous to A Breast Cancer in A 74-Year-Old Male","volume":"9","author":"Jean","year":"2023","journal-title":"J. Med. Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Abhyankar, N., Hoskins, K.F., Abern, M.R., and Calip, G.S. (2017). Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer\u2014A SEER analysis. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3640-7"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Bellini, M.I., Lori, E., Forte, F., Lauro, A., Tripodi, D., Amabile, M.I., Cantisani, V., Varanese, M., Ferent, I.C., and Baldini, E. (2022). Thyroid and renal cancers: A bidirectional association. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.951976"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_37","first-page":"567","article-title":"Familial prostate cancer and genetic predisposition","volume":"60","author":"Meissner","year":"2021","journal-title":"Der Urol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Liu, Z., Huang, Q., Ding, M., Wang, T., Chen, Y., and Zhang, K. (2024). BRCA2 mutations in familial breast cancer with prostate cancer: A case report and literature review. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1428849"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2324709619847230","DOI":"10.1177\/2324709619847230","article-title":"A Synchronous Diagnosis of Metastatic Male Breast Cancer and Prostate Cancer","volume":"7","author":"Moosavi","year":"2019","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3892\/ol.2022.13606","article-title":"Treatment of rectal cancer after previous prostate cancer: A single institution experience","volume":"25","author":"Millican","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hoshi, S., Bilim, V., Hoshi, K., Ogawa, Y., Kato, T., Urano, K., Yamada, T., Sakagami, R., Kudo, T., and Numahata, K. (2024). Double Primary Cancer of the Prostate and Urothelial Cancer: A Single Institution Experience. J. Pers. Med., 14.","DOI":"10.3390\/jpm14050510"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.2147\/OTT.S298697","article-title":"Genetic Analysis and Targeted Therapy Using Buparlisib and MK2206 in a Patient with Triple Metachronous Cancers of the Kidney, Prostate, and Squamous Cell Carcinoma of the Lung: A Case Report","volume":"14","author":"Zhao","year":"2021","journal-title":"Onco Targets Ther."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Fan, C.Y., Huang, W.Y., Lin, C.S., Su, Y.F., Lo, C.H., Tsao, C.C., Liu, M.Y., Lin, C.L., and Kao, C.H. (2017). Risk of second primary malignancies among patients with prostate cancer: A population-based cohort study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175217"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Omer, D.M., Thompson, H.M., Verheij, F.S., Yuval, J.B., Rosen, R., Beets, N.R.A., Luthra, A., Romesser, P.B., Paty, P.B., and Garcia-Aguilar, J. (2023). Rectal Cancer after Prostate Radiation: A Complex and Controversial Disease. Cancers, 15.","DOI":"10.3390\/cancers15082214"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1600::AID-CNCR24>3.0.CO;2-0","article-title":"Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma","volume":"79","author":"Neugut","year":"1997","journal-title":"Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"i851","DOI":"10.1136\/bmj.i851","article-title":"Second malignancies after radiotherapy for prostate cancer: Systematic review and meta-analysis","volume":"352","author":"Wallis","year":"2016","journal-title":"BMJ"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1666\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:45:21Z","timestamp":1760035521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,14]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medicina61091666"],"URL":"https:\/\/doi.org\/10.3390\/medicina61091666","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,14]]}}}